Inventor
BOSS CHRISTOPH
CH63 patents
⚠️ This page may combine multiple inventors who share the name “BOSS CHRISTOPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACTELION PHARMACEUTICALS LTD
14 patentsUS7285549B2Oct 23, 2007
Sulfamides and their use as endothelin receptor antagonists
ACTELION PHARMACEUTICALS LTD27 citations93
US7094781B2Aug 22, 2006
Sulfamides and their use as endothelin receptor antagonists
ACTELION PHARMACEUTICALS LTD38 citations93
US7994336B2Aug 9, 2011
Azetidine compounds as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD23 citations92
US8003654B2Aug 23, 2011
N-glycinsulfonamide derivatives and uses as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD7 citations84
US7834028B2Nov 16, 2010
Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD9 citations84
US9493446B2Nov 15, 2016
Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
ACTELION PHARMACEUTICALS LTD6 citations73
US7868012B2Jan 11, 2011
Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases
ACTELION PHARMACEUTICALS LTD4 citations63
US7452896B2Nov 18, 2008
Pyrimidine-sulfamides and their use as endothelian receptor antagonist
ACTELION PHARMACEUTICALS LTD5 citations63
US7323465B2Jan 29, 2008
Alkansulfonamides as endothelin antagonists
ACTELION PHARMACEUTICALS LTD2 citations63
US7091201B2Aug 15, 2006
Arylalkane-sulfonamides having endothelin-antagonist activity
ACTELION PHARMACEUTICALS LTD2 citations63
US9211279B2Dec 15, 2015
Proline sulfonamide derivatives as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD3 citations62
US11136317B2Oct 5, 2021
NADPH oxidase 4 inhibitors
ACTELION PHARMACEUTICALS LTD0 citations60
US9403813B2Aug 2, 2016
Azetidine amide derivatives as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD1 citations52
US6951856B2Oct 4, 2005
Arylethene-sulfonamides
ACTELION PHARMACEUTICALS LTD1 citations52
AISSAOUI HAMED
13 patentsUS8288411B2Oct 16, 2012
Pyrrolidines and piperidines as orexin receptor antagonists
AISSAOUI HAMED14 citations84
US8236964B2Aug 7, 2012
Thiazolidine derivatives as orexin receptor antagonists
AISSAOUI HAMED13 citations84
US8106215B2Jan 31, 2012
3-aza-bicyclo[3.3.0]octane compounds
AISSAOUI HAMED13 citations84
US8288429B2Oct 16, 2012
2-aza-bicyclo[3.3.0]octane derivatives
AISSAOUI HAMED15 citations83
US8288435B2Oct 16, 2012
2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
AISSAOUI HAMED11 citations83
US8063099B2Nov 22, 2011
Trans-3-aza-bicyclo[3.1.0]hexane derivatives
AISSAOUI HAMED7 citations82
US8188082B2May 29, 2012
5,6,7,8-tetrahydro-imidazo[1,5-α]pyrazine derivatives
AISSAOUI HAMED8 citations78
US9242970B2Jan 26, 2016
Lactam derivatives useful as orexin receptor antagonists
AISSAOUI HAMED3 citations72
US8236801B2Aug 7, 2012
2-aza-bicyclo[2.2.1]heptane derivatives
AISSAOUI HAMED6 citations72
US9096595B2Aug 4, 2015
7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators
AISSAOUI HAMED4 citations69
US8889688B2Nov 18, 2014
Piperazines as antimalarial agents
AISSAOUI HAMED2 citations62
US8133901B2Mar 13, 2012
3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
AISSAOUI HAMED4 citations62
US8575158B2Nov 5, 2013
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
AISSAOUI HAMED2 citations60
IDORSIA PHARMACEUTICALS LTD
13 patentsUS9732075B2Aug 15, 2017
Benzimidazole-proline derivatives
IDORSIA PHARMACEUTICALS LTD8 citations82
US11325899B2May 10, 2022
Benzofurane and benzothiophene derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD6 citations73
US10329287B2Jun 25, 2019
Benzimidazole-proline derivatives
IDORSIA PHARMACEUTICALS LTD3 citations72
US10023560B2Jul 17, 2018
Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
IDORSIA PHARMACEUTICALS LTD3 citations72
US9914720B2Mar 13, 2018
Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
IDORSIA PHARMACEUTICALS LTD3 citations72
US9790208B2Oct 17, 2017
Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
IDORSIA PHARMACEUTICALS LTD4 citations72
US11712438B2Aug 1, 2023
Phenyl derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations71
US11446298B2Sep 20, 2022
Pyrimidine derivatives
IDORSIA PHARMACEUTICALS LTD5 citations71
US9914721B2Mar 13, 2018
Use of benzimidazole-proline derivatives
IDORSIA PHARMACEUTICALS LTD4 citations71
US9879006B2Jan 30, 2018
Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations70
US11839613B2Dec 12, 2023
Pyrimidine derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD1 citations61
US11040966B2Jun 22, 2021
Benzimidazole-proline derivatives
IDORSIA PHARMACEUTICALS LTD0 citations60
US11267824B2Mar 8, 2022
Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase
IDORSIA PHARMACEUTICALS LTD1 citations56
BOLLI MARTIN
3 patentsUS9150566B2Oct 6, 2015
2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists
BOLLI MARTIN7 citations83
US8324232B2Dec 4, 2012
4-pyrimidinesulfamide derivative
BOLLI MARTIN13 citations81
US9303023B2Apr 5, 2016
Pyrazole and imidazole derivatives useful as orexin antagonists
BOLLI MARTIN1 citations51
ARVINMERITOR GMBH
2 patentsBOSS CHRISTOPH
2 patentsBINKERT CHRISTOPH
1 patentMERITOR AUTOMOTIVE GMBH
1 patentACTELIO PHARMACEUTICALS LTD
1 patentShowing the top 50 of 63 patents by PatentIndex Score.